Trends of Incident Dialysis Patients in Tunisia Between 1992 and 2001

American Journal of Kidney Diseases

Volumn 51, Issue 3, 2008, Pages 463-470

  Counil, Émilie ^a,b   Cherni, Noureddine ^c   Kharrat, Mamhoud ^d,e   Achour, Abdellatif ^d,f   Trimech, Hichem ^c  

^a AGROPARISTECH   (France)

^b LAVAL UNIVERSITY   (Canada)

^c Ministry of Health   (Tunisia)

^d Faculty of Dentistry   (Tunisia)

^e HEDI CHAKER HOSPITAL   (Tunisia)

^f SAHLOUL UNIVERSITY HOSPITAL   (Tunisia)

Author keywords

Dialysis; epidemiology; health transition; ochratoxin A; renal replacement therapy; Tunisia

Indexed keywords

OCHRATOXIN;

ADULT; AGE DISTRIBUTION; AGED; AGING; ARTICLE; DIABETIC NEPHROPATHY; ENVIRONMENTAL FACTOR; FEMALE; GEOGRAPHIC DISTRIBUTION; HEALTH CARE ACCESS; HUMAN; INCIDENCE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; REGISTER; RENAL REPLACEMENT THERAPY; RISK FACTOR; SEX RATIO; TUNISIA;

ADULT; FEMALE; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; ODDS RATIO; REGISTRIES; RENAL DIALYSIS; TUNISIA;

EID: 39449121615     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2007.10.032     Document Type: Article

References (37)

1. White S.L., Cass A., Atkins R.C., and Chadban S.J. Chronic kidney disease in the general population. Adv Chronic Kidney Dis 12 (2005) 5-13
2. Barsoum R.S. Overview: End-stage renal disease in the developing world. Artif Organs 26 (2002) 737-746
3. Barsoum R.S. End-stage renal disease in the developing world. Artif Organs 26 (2002) 735-736
4. Barsoum R.S. End-stage renal disease in North Africa. Kidney Int Suppl 83 (2003) S111-S114
5. World Bank Group. Country Classification of Economies, 2006. http://web.worldbank.org/WBSITE/EXTERNAL/DATASTATISTICS/0,,contentMDK:20420458∼menuPK:64133156∼pagePK:64133150∼piPK:64133175∼theSitePK:239419,00.html Accessed August 5, 2007
6. Stewart J.H., McCredie M.R., Williams S.M., and McDonald S.P. Interpreting incidence trends for treated end-stage renal disease: Implications for evaluating disease control in Australia. Nephrology 9 (2004) 238-246
7. Barsoum R.S. Chronic kidney disease in the developing world. N Engl J Med 354 (2006) 997-999
8. Institut National de la Statistique (INS): Annuaire statistique de la Tunisie. République Tunisienne-Ministère du Développement Economique. National Annals of Statistics, 1989 to 2001 Tunis, République Tunisienne, Ministère du Développement Economique
9. ERA-EDTA Registry. ERA-EDTA Registry 2001 Annual Report. Academic Medical Center, Amsterdam, The Netherlands, 2003. http://www.era-edta-reg.org/files/annualreports/pdf/AnnRep2001.pdf Accessed August 5, 2007
10. Stengel B., Billon S., Van Dijk P.C., et al. Trends in the incidence of renal replacement therapy for end-stage renal disease in Europe, 1990-1999. Nephrol Dial Transplant 18 (2003) 1824-1833
11. Canadian Institute for Health Information (CIHI). Canadian Organ Replacement Register 2001 Report. Volume 1: Dialysis and Renal Transplantation (includes data 1981-1999) (2001), CIHI, Ottawa, Canada
12. Jager K.J., van Dijk P.C., Dekker F.W., Stengel B., Simpson K., and Briggs J.D. The epidemic of aging in renal replacement therapy: An update on elderly patients and their outcomes. Clin Nephrol 60 (2003) 352-360
13. Jacobs C., and Selwood N. Renal replacement therapy for end-stage renal failure in France: Current status and evolutive trends over the last decade. Am J Kidney Dis 25 (1995) 188-195
14. US Renal Data System. USRDS 2004 Annual Data Report. The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2004. http://www.usrds.org/adr_2004.htm Accessed August 5, 2007
15. Yamagata K., Takahashi H., Suzuki S., et al. Age distribution and yearly changes in the incidence of ESRD in Japan. Am J Kidney Dis 43 (2004) 433-443
16. McDonald S., Russ G., Kerr P., and Collins J. ESRD in Australia and New Zealand at the end of the millenium: A report from the ANZDATA registry. Am J Kidney Dis 40 (2002) 1122-1131
17. Feest T., Rajamahesh J., Byrne C., et al. Trends in adult renal replacement therapy in the UK: 1982-2002. QJM 98 (2005) 21-28
18. Stanton J. The costs of living: Kidneys, dialysis, rationing and health economics in Britain, 1995-96. Soc Sci Med 49 (1999) 1169-1182
19. Moulton L.H., Port F.K., Wolfe R.A., Foxman B., and Guire K.E. Patterns of low incidence of treated end-stage renal disease among the elderly. Am J Kidney Dis 20 (1992) 55-62
20. Omran A.R. The epidemiologic transition: A theory of the epidemiology of population change. Milbank Mem Fund Q 49 (1971) 509-538
21. Bouguerra R., Alberti H., Salem L.B., et al. The global diabetes pandemic: The Tunisian experience. Eur J Clin Nutr 61 (2007) 160-165
22. Gilles H.M. Reflections on the ageing in the tropical world. Bold 14 (2004) 17-22
23. Ben Romdhane H., Khaldi R., Oueslati A., and Skhiri H. Transition épidémiologique et transition alimentaire et nutritionnelle en Tunisie. IHEAM-Options Méditerranéennes, Série B 41 (2002) 7-27
24. Ben Hamida A., Fakhfakh R., Miladi W., Zouari B., and Nacet T. Health transition in Tunisia over the past 50 years. East Mediterr Health J 11 (2005) 181-191
25. Ceovic S., Hrabar A., and Saric M. Epidemiology of Balkan endemic nephropathy. Food Chem Toxicol 30 (1992) 183-188
26. Maaroufi K., Achour A., Betbeder A.M., et al. Foodstuffs and human blood contamination by the mycotoxin ochratoxin A: Correlation with chronic interstitial nephropathy in Tunisia. Arch Toxicol 69 (1995) 552-558
27. Maaroufi K., Achour A., Hammami M., et al. Ochratoxin A in human blood in relation to nephropathy in Tunisia. Hum Exp Toxicol 14 (1995) 609-615
28. Mihatsch M.J., Gudat F., Zollinger H.U., Heierli C., Thölen H., and Reutter F.W. Systemic karyomegaly associated with chronic interstitial nephritis. A new disease entity?. Clin Nephrol 12 (1979) 54-62
29. Spoendlin M., Moch H., Brunner F., et al. Karyomegalic interstitial nephritis: Further support for a distinct entity and evidence for a genetic defect. Am J Kidney Dis 25 (1995) 242-252
30. Maaroufi K., Zakhama A., Baudrimont I., et al. Karyomegaly of tubular cells as early stage marker of the nephrotoxicity induced by ochratoxin A in rats. Hum Exp Toxicol 18 (1999) 410-415
31. Abid S., Hassen W., Achour A., et al. Ochratoxin A and human chronic nephropathy in Tunisia: Is the situation endemic?. Hum Exp Toxicol 22 (2003) 77-84
32. Hassen W., Abid-Essafi S., Achour A., et al. Karyomegaly of tubular kidney cells in human chronic interstitial nephropathy in Tunisia: Respective role of ochratoxin A and possible genetic predisposition. Hum Exp Toxicol 23 (2004) 339-346
33. Ball S., Lloyd J., Cairns T., et al. Why is there so much end-stage renal failure of undetermined cause in UK Indo-Asians?. QJM 94 (2001) 187-193
34. Aviles-Gomez R., Luquin-Arellano V.H., Garcia-Garcia G., Ibarra-Hernandez M., and Briseño-Renteria G. Is renal replacement therapy for all possible in developing countries?. Ethn Dis 6 suppl 2 (2006) S2-70-S2-2
35. Levey A.S., Andreoli S.P., DuBose T., Provenzano R., and Collins A.J. CKD: Common, harmful, and treatable-World Kidney Day 2007. Am J Kidney Dis 49 (2007) 175-179
36. Institut National de la Statistique (INS): Enquête Nationale sur le Budget, la Consommation et le Niveau de Vie des Ménages 2000-Volume A: Résultats de l'Enquête sur le Budget des Ménages, In Ministère du Développement Economique: République Tunisienne, 2000. http://www.ins.nat.tn/indexfr.php Accessed August 5, 2007
37. Institut National de la Statistique (INS). Annuaire statistique de la Tunisie. National Annals of Statistics, 2000. République Tunisienne-Ministère du Développement Economique. Report nr 43, Tunis, République Tunisienne, Ministère du Développement Economique, 2000